Although in principle we confirmed the beneficial effect of neutralizing IFN-γ and IL-6 for the host regarding the respiratory bacterial burden in secondary pneumococcal infection following influenza infection, there were substantial discrepancies between the predictions of mathematical modeling and our experimental results when attempting to validate these predictions in vivo. The gene discussed is IL6; the disease is influenza.